Antigenics, Inc., a clinical-stage biopharmaceutical company, discovers, manufactures, and develops immunotherapies for cancer. The company was founded in 1994 and is based in Lexington, Massachusetts.
Frequently asked questions
What sector does Antigenics Inc (ANTI) operate in?
Antigenics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Antigenics Inc (ANTI) current stock price?
As of the latest data, Antigenics Inc stock price is $147.49, with a previous close of $147.49.
Does Antigenics Inc (ANTI) pay dividends?
No. Antigenics Inc does not pay a dividend.
What is Antigenics Inc (ANTI) beta (volatility) score?
Antigenics Inc has a beta of -70225.419, indicating lower volatility than the overall market.